Skip to content

ESD Home

TechCentury

Powered by

Engineering Society of Detroit Lawrence Technological University

Tag: Endocrine Diseases

Pharmaceuticals / Startups

Millendo names chief commercial officer

ANN ARBOR—Millendo Therapeutics Inc. (Nasdaq: MLND), the developer of new endocrine drugs, announced the promotion of Thomas Hoover to the newly created position of chief commercial officer. Hoover joined Millendo …

Pharmaceuticals

Ann Arbor Pharma Firm Gets $62M To Commercialize Drug For Ovarian Disease

ANN ARBOR — Millendo Therapeutics Inc., the Ann Arbor pharma firm, announced an exclusive license agreement with the pharmaceutical giant AstraZeneca for the worldwide development and commercialization rights to AZD4901, …

TechCentury
Advertise or Contribute an Article
Lawrence Technological University
MITechNews.com

Subscribe to TechCentury.com

Top Posts

  • Google picks Invest Detroit's VC unit to help startups in Michigan
  • Apply for SME Education Foundation scholarships through Feb. 1
  • Community development projects get state aid
  • A long road ahead to self-driving cars: WWJ panel at LTU
  • Production Tool to establish HQ in Novi

Archives

Follow Us On

© The Engineering Society of Detroit   |   ABOUT